These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 112008)

  • 21. [Hypercoagulability and cerebral infarction].
    Matsuda T
    No To Shinkei; 1986 Apr; 38(4):317-27. PubMed ID: 3013261
    [No Abstract]   [Full Text] [Related]  

  • 22. [Blood platelets and myocardial infarction].
    Musiał J; Dworski R; Szczeklik A
    Pol Tyg Lek; 1984 Dec; 39(50):1665-8. PubMed ID: 6396594
    [No Abstract]   [Full Text] [Related]  

  • 23. Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets.
    Fabris F; Casonato A; Randi ML; Schivazappa L; Schiavinato L; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):594-601. PubMed ID: 6196274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trials of antiplatelet drugs: some methodological considerations.
    Armitage P
    Rev Epidemiol Sante Publique; 1979 Sep; 27(2):87-90. PubMed ID: 538303
    [No Abstract]   [Full Text] [Related]  

  • 25. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
    Verdecchia P
    G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of ticlopidine on platelet function at rest and after exercise in patients with previous myocardial infarct. An acute crossover double-blind study].
    Tullio D; Valerio A; Ottaviano MA; Di Guglielmo L; Accettura P; Caraceni CE; Sclocco T
    Minerva Med; 1990; 81(1-2):87-92. PubMed ID: 2179769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
    Bousser MG
    J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of sulfinpyrazone on the platelet function and in experimental thrombosis].
    Haas S; Ketterl R; Blümel G
    Fortschr Med; 1981 Jan; 99(4):113-8. PubMed ID: 7274948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Anturane reinfarction trial.
    Sherry S
    Thromb Haemost; 1979 Feb; 41(1):197-201. PubMed ID: 483231
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of spontaneous platelet aggregation by sulfinpyrazone.
    Nenci GG; Agnelli G; Berrettini M; Parise P; Ballatori E
    Thromb Haemost; 1979 Aug; 42(2):621-5. PubMed ID: 505369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 32. [Interaction of sulfinpyrazone (Anturan) and glibenclamide (Euglucon) in type II diabetic patients].
    Kritz H; Najemnik C; Irsigler K
    Wien Med Wochenschr; 1983 May; 133(9):237-43. PubMed ID: 6408808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Personal experience with the administration of sulfinpyrazone to patients with kidney failure].
    Opatrný K; Cepelák V; Opatrný K; Valenta J; Cepeláková H; Sefrna F
    Vnitr Lek; 1986 Jul; 32(7):673-80. PubMed ID: 3526712
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of platelet-active drugs in coronary artery disease.
    Sherry S
    Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
    [No Abstract]   [Full Text] [Related]  

  • 35. Platelet aggregation and atherosclerosis.
    Valladares BK; Lemberg L
    Heart Lung; 1986 Mar; 15(2):211-4. PubMed ID: 3633253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet function in acute myocardial infarction patients compared with controls.
    O'Brien JR; Etherington MD; Shuttleworth RD; Calwell WH
    Thromb Haemost; 1980 Oct; 44(2):96-9. PubMed ID: 7455998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence on platelet function by heparin in men with unstable coronary artery disease.
    Berglund U; Wallentin L
    Thromb Haemost; 1991 Dec; 66(6):648-51. PubMed ID: 1796408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Platelet inhibitory agents in the prevention of infarct].
    Stormorken H
    Tidsskr Nor Laegeforen; 1978 Oct; 98(30):1523-4. PubMed ID: 725864
    [No Abstract]   [Full Text] [Related]  

  • 39. Double-blind comparison of ketanserin with atenolol: antihypertensive activity and effect on platelet function.
    Kirch W; Ohnhaus EE
    J Hypertens Suppl; 1986 Apr; 4(1):S67-71. PubMed ID: 2939216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The Anturan reinfarct study].
    Sherry S
    Wien Med Wochenschr Suppl; 1980; 61():17-22. PubMed ID: 6930766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.